Search research articles
Contact Us
Filters
Showing results (41-50 of 174) with videos related to
Page
of 18
Sort By:
Cancer Immunology, Immunotherapy : CII
|
October 26, 2001
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells
L Ragnarsson, T Strömberg, J Wijdenes, et al.
Biochemistry
|
March 22, 1988
Evidence for a polypeptide segment at the carboxyl terminus of recombinant human gamma interferon involved in expression of biological activity
G F Seelig, J Wijdenes, T L Nagabhushan, et al.
Cancer Research
|
April 15, 1996
CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation
C Pellat-Deceunynck, M Amiot, N Robillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1987
Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE
J Y Bonnefoy, J P Aubry, C Peronne, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Monoclonal antibodies define different functional epitopes on gp130 signal transducer
S Chevalier, C Clement, O Robledo, et al.
The Journal of Biological Chemistry
|
February 15, 2000
Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies
G Müller-Newen, A Küster, J Wijdenes, et al.
European Journal of Immunology
|
March 1, 1996
Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12
T Jung, J Wijdenes, C Neumann, et al.
Clinical Intensive Care : International Journal of Critical & Coronary Care Medicine
|
December 9, 1994
Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock
A Boillot, G Capellier, E Racadot, et al.
Transplantation Proceedings
|
April 1, 1995
Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation
E Racadot, C Mousson, Y Tanter, et al.
Journal of Interferon Research
|
October 1, 1994
Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodies
F A Montero-Julian, E Gautherot, J Wijdenes, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 174) with videos related to
Sort By:
Page
of 18
Cancer Immunology, Immunotherapy : CII
|
October 26, 2001
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells
L Ragnarsson, T Strömberg, J Wijdenes, et al.
Biochemistry
|
March 22, 1988
Evidence for a polypeptide segment at the carboxyl terminus of recombinant human gamma interferon involved in expression of biological activity
G F Seelig, J Wijdenes, T L Nagabhushan, et al.
Cancer Research
|
April 15, 1996
CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation
C Pellat-Deceunynck, M Amiot, N Robillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1987
Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE
J Y Bonnefoy, J P Aubry, C Peronne, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Monoclonal antibodies define different functional epitopes on gp130 signal transducer
S Chevalier, C Clement, O Robledo, et al.
The Journal of Biological Chemistry
|
February 15, 2000
Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies
G Müller-Newen, A Küster, J Wijdenes, et al.
European Journal of Immunology
|
March 1, 1996
Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12
T Jung, J Wijdenes, C Neumann, et al.
Clinical Intensive Care : International Journal of Critical & Coronary Care Medicine
|
December 9, 1994
Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock
A Boillot, G Capellier, E Racadot, et al.
Transplantation Proceedings
|
April 1, 1995
Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation
E Racadot, C Mousson, Y Tanter, et al.
Journal of Interferon Research
|
October 1, 1994
Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodies
F A Montero-Julian, E Gautherot, J Wijdenes, et al.
Page
of 18